Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Leukemia & Lymphoma
|
May 1, 1993
Clinical significance of bcr-abl gene rearrangement detected by the polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia
G Pichert, J Ritz
Schweizerische Medizinische Wochenschrift
|
November 21, 1987
[Conservative therapy of chronic subdural hematomas]
G Pichert, V Henn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2000
Organizing cancer genetics programs: the Swiss model
G Pichert, R A Stahel
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2001
Cancer genetics in oncology practice
O I Olopade, G Pichert
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1990
Placebo controlled phase I/II study of subcutaneous GM-CSF in patients with germ cell tumors undergoing chemotherapy
L M Jost, G Pichert, R A Stahel
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2002
Evidence-based management options for women at increased breast/ovarian cancer risk
G Pichert, B Bolliger, K Buser, et al.
British Journal of Haematology
|
August 12, 1999
Involvement of the CD27-CD70 co-stimulatory pathway in allogeneic T-cell response to follicular lymphoma cells
D Schmitter, U Bolliger, M Hallek, et al.
Blood
|
October 15, 1996
Fate of contaminating t(14; 18)+ lymphoma cells during ex vivo expansion of CD34-selected hematopoietic progenitor cells
L Widmer, G Pichert, L M Jost, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2003
Severe hepatic toxicity due to thalidomide in relapsed multiple myeloma
A Trojan, E Chasse, B Gay, et al.
British Journal of Cancer
|
February 1, 1991
Clinical and immune modulatory effects of alternative weekly interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma and melanoma
G Pichert, L M Jost, W Fierz, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Leukemia & Lymphoma
|
May 1, 1993
Clinical significance of bcr-abl gene rearrangement detected by the polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia
G Pichert, J Ritz
Schweizerische Medizinische Wochenschrift
|
November 21, 1987
[Conservative therapy of chronic subdural hematomas]
G Pichert, V Henn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2000
Organizing cancer genetics programs: the Swiss model
G Pichert, R A Stahel
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2001
Cancer genetics in oncology practice
O I Olopade, G Pichert
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1990
Placebo controlled phase I/II study of subcutaneous GM-CSF in patients with germ cell tumors undergoing chemotherapy
L M Jost, G Pichert, R A Stahel
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2002
Evidence-based management options for women at increased breast/ovarian cancer risk
G Pichert, B Bolliger, K Buser, et al.
British Journal of Haematology
|
August 12, 1999
Involvement of the CD27-CD70 co-stimulatory pathway in allogeneic T-cell response to follicular lymphoma cells
D Schmitter, U Bolliger, M Hallek, et al.
Blood
|
October 15, 1996
Fate of contaminating t(14; 18)+ lymphoma cells during ex vivo expansion of CD34-selected hematopoietic progenitor cells
L Widmer, G Pichert, L M Jost, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2003
Severe hepatic toxicity due to thalidomide in relapsed multiple myeloma
A Trojan, E Chasse, B Gay, et al.
British Journal of Cancer
|
February 1, 1991
Clinical and immune modulatory effects of alternative weekly interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma and melanoma
G Pichert, L M Jost, W Fierz, et al.
Page
of 3